PMAM
AEON.WS

Picton Mahoney Asset Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Picton Mahoney Asset Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-116,666
Closed -$36K – 932
2022
Q1 		$36K Hold
116,666
– – ﹤0.01% 739
2021
Q4 		$60K Hold
116,666
– – ﹤0.01% 770
2021
Q3 		$68K Hold
116,666
– – ﹤0.01% 664
2021
Q2 		$117K Buy
+116,666
New +$88.5K ﹤0.01% 644

Other funds holding AEON.WS

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Picton Mahoney Asset Management's AEON.WS Position: Q2 2022 in Review

Picton Mahoney Asset Management sold out of AEON Biopharma Inc (AEON.WS) in Q2 2022, closing a stake of 116,666 shares — an estimated $36K sold.

Picton Mahoney Asset Management first reported a position in AEON.WS in Q2 2021 and held it in 4 quarters. The position peaked at $117K in Q2 2021. 52 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2022.

  • Picton Mahoney Asset Management reported no remaining AEON Biopharma Inc position as of Q2 2022 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 116,666 AEON Biopharma Inc shares in Q2 2022, an estimated $36K.
  • Picton Mahoney Asset Management first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 4 quarters.
  • Picton Mahoney Asset Management's AEON Biopharma Inc position peaked at $117K in Q2 2021.
  • 52 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.